Posted in | News

Skanska Begins New Residential Construction in Oslo, Norway

Skanska, in cooperation with the property company Ferd Eiendom, is starting a new residential area in Oslo, Norway. Skanska’s share of the investment is amounting to approximately NOK 220 M, about SEK 250 M. Skanska is responsible for the entire construction contract, which amounts to NOK 312 M, about SEK 360 M, which will be included in fourth-quarter order bookings.

Skanska Residential Development Nordic and Ferd Eiendom each hold a 50-percent share in the Tiedemannsbyen project company which is the investor in land and buildings for the project.

The first phase of the new Tiedemannsbyen neighborhood will include apartment blocks with 174 units and 25 row houses, in addition to parking for cars and bikes. This is the first of three phases which are planned for the former industrial area that was the site of the Tiedemanns tobacco plant in the Ensjø district of Oslo.

In collaboration with Oslo Municipality, a green profile will be created for the area involving renewable energy, environmentally friendly materials and the preservation of nature values.

Construction work will commence in January 2011 and will be completed by April 2013.

Skanska Residential Development Nordic initiates and develops residential areas for apartment blocks and single-family homes. At mid-2010, the business area had approximately 3,300 new homes in production, of which about 3.000 in the Nordics. About 350 employees are active within Skanska Residential Development in Sweden, Skanska Kodit in Finland and Skanska Bolig in Norway.

Source: http://www.skanska.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.